RETRACTED: High-throughput sequencing in diagnostics and prevention of herpes simplex virus infection (Herpesviridae, Alphaherpesvirinae, Simplexvirus, Human alphaherpesvirus 1)
- Authors: Sergeyev O.V.1, Bosh’ian R.E.1, Barinsky I.F.2
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya
- Issue: Vol 65, No 3 (2020)
- Pages: 126-131
- Section: REVIEWS
- Submitted: 21.07.2020
- Accepted: 21.07.2020
- Published: 21.07.2020
- URL: https://virusjour.crie.ru/jour/article/view/385
- DOI: https://doi.org/10.36233/0507-4088-2020-65-3-126-131
- ID: 385
Cite item
Full Text
Abstract
Herpes simplex viruses types 1 (HSV-1) and 2 (HSV-2) are among the most common viruses in the human population. The clinical manifestations of HSV infection vary widely, which necessitates reliable molecular methods for the timely diagnosis of herpes virus infection, as well as for detection of mutations in the genes responsible for drug resistance. PCR is often unable to detect HSV isolates with nucleotide substitutions at the primer binding site. Sanger sequencing of the whole genome reveals mutations mainly at the consensus level, which accumulate at advanced stages of viral infection. High-throughput sequencing (HTS, next generation sequencing) offers an obvious advantage both in early diagnosis of herpes virus infection and identification of HSV variants.
About the authors
O. V. Sergeyev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: osergeyev123@gmail.com
ORCID iD: 0000-0003-3407-2224
Oleg V. Sergeyev, Doct. Sci. (Biol.), Professor at the Department of microbiology, virology and immunology
Moscow, 119991
Russian FederationR. E. Bosh’ian
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: fake@neicon.ru
ORCID iD: 0000-0003-4789-4964
Roman E. Bosh’ian
Moscow, 119991
Russian FederationI. F. Barinsky
National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya
Email: fake@neicon.ru
ORCID iD: 0000-0002-9909-3598
Igor F. Barinsky
Moscow, 123098
Russian FederationReferences
- WHO. Fact sheet. Herpes simplex virus. Available at: https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus
- Looker K.J., Magaret A.S., Turner K.M.E., Vickerman P., Gottlieb S.L., Newman L.M. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PloS One. 2015; 10(1): el14989. DOI: http://doi.org/10.1371/journal.pone.0114989
- Corey L., Wald A., Celum C.L., Quinn T.C. The effects of herpes simplex virus-2 on HIV-l acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr. 2004; 35(5): 435-45. DOI: http://doi.org/10.1097/00126334-200404150-00001
- Knipe D.M., Howley P. Fields Virology. New York: Lippincott Williams & Wilkins; 2013.
- Behjati S., Tarpey P.S. What is next generation sequencing? Arch. Dis. Child. Educ. Pract. Ed. 2013; 98(6): 236-8. DOI: http://doi.org/10.1136/archdischild-2013-304340
- Handelsman J. Metagenomics: application of genomics to uncultured microorganisms. Microbiol. Mol. Biol. Rev. 2004; 68(4): 669- 85. DOI: http://doi.org/10.1128/MMBR.68.4.669-685.2004
- Deurenberg R.H., Bathoorn E., Chlebowicz M.A., Couto N., Ferdous M., Garcia-Cobos S., et al. Application of next generation sequencing in clinical microbiology and infection prevention. J. Biotechnol. 2017; 243: 16-24. DOI: http://doi.org/10.1016/j.jbiotec.2016.12.022
- Buchman T.G., Simpson T., Nosal C., Roizman B., Nahmias A.J. The structure of herpes simplex virus DNA and its application to molecular epidemiology. Ann. NY Acad. Sci. 1980; 354: 279-90. DOI: http://doi.org/10.1111/j.1749-6632.1980.tb27972.x
- Szpara M.L., Gatherer D., Ochoa A., Greenbaum B., Dolan A., Bowden R.J., et al. Evolution and diversity in human herpes simplex virus genomes. J. Virol. 2014; 88(2): 1209-27. DOI: http://doi.org/10.1128/JVI.01987-13
- Renzette N., Gibson L., Bhattacharjee В., Fisher D., Schleiss M.R., Jensen J.D., et al. Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection. PLoS Genet. 2013; 9(9): e1003735. DOI: http://doi.org/10.1371/journal.pgen.1003735
- Sanjuán R., Domingo-Calap P. Mechanisms of viral mutation. Cell. Mol. Life Sci. 2016; 73(23): 4433-48. DOI: http://doi.org/10.1007/s00018-016-2299-6
- Drake J.W., Hwang C.B.C. On the mutation rate of herpes simplex virus type I. Genetics. 2005; 170(2): 969-70. DOI: http://doi.org/10.1534/genetics.104.040410
- Szpara M.L., Tafuri Y.R., Parsons L., Shamim S.R., Verstrepen K.J., Legendre M., et al. A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses. PLoS Pathog. 2011; 7(10): 1-23. DOI: http://doi.org/10.1371/journal.ppat.1002282
- Pandey U., Bell A.S., Renner D.W., Kennedy D.A., Shreve J.T., Cairns C.L., et al. DNA from dust: comparative genomics of large DNA viruses in field surveillance samples. mSphere. 2016; 1(5): e00132-16. DOI: http://doi.org/10.1128/mSphere.00132-16
- Pandey U., Renner D.W., Thompson R.L., Szpara M.L., Sawtell N.M. Inferred father-to-son transmission of herpes simplex virus results in near-perfect preservation of viral genome identity and in vivo phenotypes. Sci. Rep. 2017; 7(1): 13666. DOI: http://doi.org/10.1038/s41598-017-13936-6
- Morfin F., Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J. Clin. Virol. 2003; 26(1): 29-37. DOI: http://doi.org/10.1016/s1386-6532(02)00263-9
- Fujii H., Kakiuchi S., Tsuji M., Nishimura H., Yoshikawa T., Yamada S., et al. Application of next-generation sequencing to detect acyclovir-resistant herpes simplex virus type 1 variants at low frequency in thymidine kinase gene of the isolates recovered from patients with hematopoietic stem cell transplantation. J. Virol. Methods. 2018; 251: 123-8. DOI: http://doi.org/10.1016/j.jviromet.2017.10.019
- Somasekar S., Lee D., Rule J., Naccache S.N., Stone M., Busch M.P., el al. Viral surveillance in serum samples from patients with acute liver failure by metagenomic next-generation sequencing. Clin. Infect. Dis. 2017; 65(9): 1477-85. DOI: http://doi.org/10.1093/cid/cix596
- Mercier-Darty M., Boutolleau D., Lepeule R., Rodriguez C., Burrel S. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations. Antiviral Res. 2018; 151: 20-3. DOI: http://doi.org/10.1016/j.antiviral.2018.01.008
- Houldcroft C.J., Bryant J.M., Depledge D.P., Margetts B.K., Simmonds J., Nicolaou S., et al. Detection of low frequency multi-drug resistance and novel putative maribavir resistance in immunocompromised pediatric patients with cytomegalovirus. Front. Microbiol. 2016; 7: 1317. DOI: http://doi.org/10.3389/fmicb.2016.01317
- Bowden R., Sakaoka H., Donnelly P., Ward R. High recombination rate in herpes simplex virus tyре 1 natural populations suggests significant co-infection. Infect. Genet. Evol. 2004; 4(2): 115-23. DOI: http://doi.org/10.1016/j.meegid.2004.01.009
- Lee S.W., Markham P.F., Coppo M.J., Legione A.R., Markham J.F., Noormohammadi A.H., et al. Attenuated vaccines can recombine to form virulent field viruses. Science. 2012; 37(6091): 188. DOI: http://doi.org/10.1126/science.1217134
- Lee K., Kolb A.W., Sverchkov Y., Cuellar J.A., Craven M., Brandt C.R. Recombination analysis of herpes simplex virus 1 reveals a bias toward GC content and the inverted repeat regions. J. Virol. 2015; 89(14): 7214-23. DOI: http://doi.org/10.1128/JVI.00880-15
- Kolb A.W., Lee K., Larsen I., Craven M., Brandt C.R. Quantitative trait locus based virulence determinant mapping of the HSV-1 genome in murine ocular infection: genes involved in viral regulatory and innate immune networks contribute to virulence. PLoS Pathog. 2016; 12(3): e1005499. DOI: http://doi.org/10.1371/journal.ppat.1005499
- Koelle D.M., Norberg P., Fitzgibbon M.P., Russell R.M., Greninger A.L., Huang M.L., et al. Worldwide circulation of HSV-2 x HSV- 1 recombinant strains. Sci. Rep. 2017; 7: 44084. DOI: http://doi.org/10.1038/srep44084
- Javier R.T., Sedarati F., Stevens J.G. Two avirulent herpes simplex viruses generate lethal recombinants in vivo. Science. 1986; 234(4777): 746-8. DOI: http://doi.org/10.1126/science.3022376
- Lassalle F., Depledge D.P., Reeves M.B., Brown A.C., Christiansen M.T., Tutill H.J., et al. Islands of linkage in an ocean of pervasive recombination reveals two-speed evolution of human cytomegalovirus genomes. Virus Evol. 2016; 2(1): vew017. DOI: http://doi.org/10.1093/ve/vew017
- Kriesel J.D., Bhatia A., Thomas A. Cold sore susceptibility gene-1 genotypes affect the expression of herpes labialis in unrelated human subjects. Hum. Genome Var. 2014; 1: 14024. DOI: http://doi.org/10.1038/hgv.2014.24
- Thompson R.L., Williams R.W., Kotb M., Sawtell N.M. A forward phenotypically driven unbiased genetic analysis of host genes that moderate herpes simplex virus virulence and stromal keratitis in mice. PLoS One. 2014; 9(3): e92342. DOI: http://doi.org/10.1371/journal.pone.0092342
- Shipley M.M., Renner D.W., Ott M., Bloom D.C., Koelle D.M., Johnston C., et al Genome-wide surveillance of genital herpes simplex virus type 1 from multiple anatomic over time. J. Infect. Dis. 2018; 218(4): 595-605. DOI: http://doi.org/10.1093/infdis/jiy216
- Kleinstein S.E., Shea P.R., Allen A.S., Koelle D.M., Wald A., Goldstein D.B. Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2). Genes Immun. 2018; 20(2): 112-20. DOI: http://doi.org/10.1038/s41435-018-0013-4
- Johnston C., Koelle D.M., Wald A. Current status and prospects for development of an HSV vaccine. Vaccine. 2014; 32(14): 1553-60. DOI: http://doi.org/10.1016/j.vaccine.2013.08.066
- Newman R.M., Lamers S.L., Weiner B., Ray S.C., Colgrove R.C., Diaz F., et al. Genome sequencing and analysis of geographically diverse clinical isolates of herpes simplex virus 2. J. Virol. 2015; 89(16): 8219-32. DOI: http://doi.org/10.1128/JVI.01303-15
- Johnston С., Magaret A., Roychoudhury P., Greninger A.L., Reeves D., Schiffer J., et al. Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: a nested cross-sectional viral genotyping study. PLoS Med. 2017; 14(12): e1002475. DOI: http://doi.org/10.1371/journal.pmed.1002475
- Anderson T.P., Werno A.M., Beynon K.A., Murdoch D.R. Failure to genotype herpes simplex virus by real-time PCR assay and melting curve analysis due to sequence variation within probe binding sites. J. Clin. Microbiol. 2003; 41(5): 2135-7. DOI: http://doi.org/10.1128/jcm.41.5.2135-2137.2003
- Wald A., Corey L. Persistence in the population: epidemiology, transmission. In: Arvin A., Campadelli-Fiume G., Mocarski E., Moore P.S., Roizman B., Whitley R., et al. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007.
- Sataoka H., Saheki Y., Uzuki K., Nakakita T., Saito H., Sekine K., et al. Two outbreaks of herpes simplex virus type 1 nosocomial infection among newborns. J. Clin. Microbiol. 1986; 24(1): 36-40.
- Gutiérrez S., Michalakis Y., Blanc S. Virus population bottlenecks during within-host progression and host-to-host transmission. Curr. Opin. Virol. 2012; 2(5): 546-55. DOI: http://doi.org/10.1016/j.coviro.2012.08.001
- Nakamura K., Oshima T., Morimoto T., Ikeda S., Yoshikawa H., Shiwa Y., et al. Sequence-specific error profile of Illumina sequencers. Nucleic Acids Res. 2011; 39(13): e90. DOI: http://doi.org/10.1093/nar/gkr344
- Greninger A.L., Roychoudhury P., Xie H., Casto A., Cent A., Pepper G., et al. Ultrasensitive capture of human herpes simplex virus genomes directly from clinical samples reveals extraordinarily limited evolution in cell culture. mSphere. 2018; 3(3): e00283-18. DOI: http://doi.org/10.1128/mSphereDirect.00283-18
- Guan H., Shen A., Lv X., Yang X., Ren H., Zhao Y., et al. Detection of virus in CSF from the cases with meningoencephalitis by next-generation sequencing. J. Neurovirol. 2016; 22(2): 240-5. DOI: http://doi.org/10.1007/s13365-015-0390-7
- Naccache S.N., Federman S., Veeeraraghavan N., Zaharia M., Lee D., Samayoa E., et al. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res. 2014; 24(7): 1180-92. DOI: http://doi.org/10.1101/gr.171934.113
- Oliver G.R., Hart S.N., Klee E.W. Bioinformatics for clinical next generation sequencing. Clin. Chem. 2015; 61(1): 124-35. DOI: http://doi.org/10.1373/clinchem.2014.224360
- Parsons L.R., Tafuri Y.R., Shreve J.T., Bowen C.D., Shipley M.M., Enquist L.W., et al. Rapid genome assembly and comparison decode intrastrain variation in human alphaherpesviruses. mBio. 2015; 6(2): e02213-14. DOI: http://doi.org/10.1128/mBio.02213-14
- Wan Y., Renner D.W., Albert I., Szpara M.L. VirAmp: a galaxy-based viral genome assembly pipeline. Gigascience. 2015; 4: 19. DOI: http://doi.org/10.1186/s13742-015-0060-y
- Lavezzo E., Barzon L., Toppo S., Palù G. Third generation sequencing technologies applied to diagnostic microbiology: benefits and challenges in applications and data analysis. Expert. Rev. Mol. Diagn. 2016; 16(9): 1011-23. DOI: http://doi.org/10.1080/14737159.2016.1217158